Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy-Reference-Cited by-同舟云学术

Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy

Published:2021-01-02 Issue:1 Volume:30 Page:61-76
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Liang Hanzhi¹,Du Jintong²,Elhassan Reham M.¹,Hou Xuben¹,Fang Hao¹

Affiliation:

1. Department of Medicinal Chemistry and Key Laboratory of Chemical Biology of Natural Products (MOE), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China

2. Shandong Cancer Hospital and Institute, Shandong First Medical University, Jinan, Shandong, China

Funder

the National Natural Science Foundation of China

Shandong Provincial Natural Science Foundation

China-Australia Centre for Health Sciences Research

Scholars Program of Shandong University

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2021.1850693

Reference138 articles.

1. Cyclin-dependent kinases

2. Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases

3. Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors

4. Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review

5. Treating cancer with selective CDK4/6 inhibitors

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of the CDK7 Gene, Coding for the Catalytic Subunit of the Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) and General Transcription Factor II H, by the Trans-Activator Protein Tax of Human T-Cell Leukemia Virus Type-1;Genes;2024-08-15

2. Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors;Journal for ImmunoTherapy of Cancer;2024-08

3. Protein engineering enables a soakable crystal form of human CDK7 primed for high-throughput crystallography and structure-based drug design;Structure;2024-08

4. Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers;2024-04-15

5. Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers;2024-04-15